Burke G, Esquenazi V, Gharagozloo H, Roth D, Strauss J, Kyriakides G, Milgrom M, Ranjan D, Contreras N, Rosen A
Department of Surgery, University of Miami School of Medicine.
Clin Transpl. 1989:215-28.
Of 631 renal allografts performed at our center between January 1, 1979 and June 30, 1989, 368 were from cadaver donors (CAD) and 263 were from living-related donors (LRD). The recipients were almost equally divided among 3 ethnic groups: Black, Hispanic, and non-Hispanic, non-Black (primarily of northern European background). Recipient ages ranged between 1 and 70 years. In the CAD group HLA matching was emphasized so that no patient received a kidney with less than a 1 DR match, and for the entire series there was a mean of 2.4 of 6 HLA antigens matched between donor and recipient. All patients (LRD and CAD) received at least 3 pretransplant blood transfusions. Overall actuarial 10-year patient and graft survival were 68% and 48% respectively, with 72% patient and 56% graft survival for LRD and 58% patient and 36% graft survival for CAD recipients. Factors adversely affecting long-term graft outcome were: a) Black race. Overall 10-year graft survival was 23% versus 55% for non-Blacks (p = 0.008); b) Type I Diabetes before transplant. Overall 10-year graft survival was 35% versus 51% for nondiabetics; and c) Compliance. This was the most significant factor influencing long-term survival, other than death due to cardiovascular disease. In a non-Black, nondiabetic category of less than 36 years of age at transplantation (n = 169), 10-year patient survival in LRD and CAD groups was 95% and 85%, respectively, and graft survival was 78% and 70%, respectively. This was markedly different from the entire series (p = 0.008). Even in this group, 4 of the 17 graft losses (including mortality) were due to documented prolonged noncompliance in teenagers. The 6 other deaths that occurred were due to hepatitis/cirrhosis (2), CMV (3), and AIDS (1). Among the factors not influencing graft survival in the CAD group was HLA matching after the minimum requirements were fulfilled, either by comparing 1 with 2 DR antigens, or total HLA (1-6) antigens matched.
1979年1月1日至1989年6月30日期间,在我们中心进行的631例肾移植中,368例来自尸体供者(CAD),263例来自亲属活体供者(LRD)。受者几乎平均分为3个种族:黑人、西班牙裔和非西班牙裔、非黑人(主要是北欧背景)。受者年龄在1岁至70岁之间。在CAD组中,强调HLA配型,因此没有患者接受DR配型少于1个的肾脏,并且在整个系列中,供者和受者之间6个HLA抗原的平均匹配数为2.4个。所有患者(LRD和CAD)在移植前至少接受3次输血。总体10年患者和移植物存活率分别为68%和48%,LRD组患者和移植物存活率分别为72%和56%,CAD受者患者和移植物存活率分别为58%和36%。对长期移植物结局有不利影响的因素有:a)黑人种族。总体10年移植物存活率为23%,而非黑人则为55%(p = 0.008);b)移植前的I型糖尿病。总体10年移植物存活率为35%,而非糖尿病患者为51%;c)依从性。这是影响长期存活的最显著因素,心血管疾病死亡除外。在移植时年龄小于36岁的非黑人、非糖尿病类别中(n = 169),LRD组和CAD组的10年患者存活率分别为95%和85%,移植物存活率分别为78%和70%。这与整个系列有显著差异(p = 0.008)。即使在这个组中,17例移植物丢失(包括死亡)中有4例是由于记录在案的青少年长期不依从。发生的其他6例死亡是由于肝炎/肝硬化(2例)、巨细胞病毒(3例)和艾滋病(1例)。在CAD组中,满足最低要求后,无论是比较1个与2个DR抗原,还是匹配的总HLA(1 - 6)抗原,HLA配型都不是影响移植物存活的因素。